Epinutra is a Dutch company founded to develop a novel food product based on an exciting discovery of our affiliate company Thelial Technologies S.A. We will develop a specific food ingredient that supports esophagus health in people that suffer from heartburn.
“Food can go one step further and provide targeted support for health”.
Check out our video showing some basic facts about heartburn.
Here we show how benesco works.
We are experienced in pharma/food, clinical, scaling and deal making/partnership building.
Building on current insights we are now completing the commercial formulation for launch in Q2 2020 plus expanding our clinical data-set.
Epinutra graduated from StartLife Accelerator Program (Wageningen University), in June 2019 and secured pre-seed funding . We will complete first product roll-out funded via founders and non-dilutive sources in Q2 2020. For follow-on rounds we seek aligned equity investors with a vision for development of targeted nutraceuticals. If you are interested in this opportunity please contact Richard Hampson directly: .